Polymer Factory’s warrant exercise registered with the Swedish Companies Registration Office

On 17 March 2022, the exercise period for Polymer Factory Sweden AB’s ("Polymer Factory" or the “Company") warrants of series TO 1 ended. The warrant exercise has now been registered with the Swedish Companies Registration Office (Sv. Bolagsverket).

The total number of registered shares now amounts to 6,860,398 and the share capital amounts to SEK 686,039.8. The conversion from interim shares to common shares is expected to be made on 4 April 2022 and the new shares are expected to be in each shareholder’s accounts around 4 April 2022.

For more information about Polymer Factory, please contact:
Elin Mignérus, CEO
Phone: +46 (0) 79 300 27 76
E-mail: elin.mignerus@polymerfactory.com

Polymer Factory (publ) is a leading global provider and producer of dendritic materials, with customers ranging from BigPharma, MedTech and BioTech companies, to research-intensive institutes and academic research groups. The Company’s dendritic materials act as smart delivery systems that enhance the effects of the substances they carry, e.g. a vaccine or an anticancer drug. They have also shown great promise in diagnostics, tissue engineering and in the development of vaccines. In addition, Polymer Factory has used the Company’s vast knowledge and expertise to develop a patented calibration technology, named SpheriCal®, designed for Mass Spectrometry instruments. The Company’s dendritic nanotechnologies have the potential to accelerate innovation in technologically demanding sectors, such as MedTech and BioTech. Learn more at www.polymerfactory.com.